Every week, Real Estate and Development Reporter Jim Weiker rounds up the biggest business news of the week in his Breaking Ground newsletter. Check out the May 1 edition below and follow this link to subscribe so it hits your inbox every Thursday. New …
Amgen Inc. AMGN reported first-quarter sales of $8.15 billion on Thursday, up 9% year over year and beating the consensus of $8.06 billion. Product sales grew 11%, primarily driven by 14% volume growth, partially offset by 6% lower net selling price. U.S. …
It’s been 19 months since Amgen completed its $27.8 billion acquisition of Horizon Therapeutics, and the California company is still struggling to build momentum for three of the prized possessions of the deal—rare disease drugs Uplizna, Krystexxa and …
Dive Brief: Amgen on Thursday said its just-launched biosimilar of Johnson & Johnson’s autoimmune drug Stelara recorded $150 million in sales in the first quarter, spotlighting rising revenue from the biotech’s portfolio of copycat biologics. During …
Deep-pocketed investors have adopted a bearish approach towards Amgen AMGN, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors …
Amgen Inc. (NASDAQ:AMGN) Q1 2025 Earnings Call Transcript May 1, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $4.9, expectations were $4.27. Operator: My name is Julianne and I’ll be your conference facilitator today for the Amgen Q1 FY …
Instead of slapping tariffs on pharmaceutical products, Amgen argues that domestic manufacturing could be better off with “pro-growth tax policy,” company executives said during the company’s first quarter earnings call. “To build on the manufacturing base …
Audio By Carbonatix By Deena Beasley (Reuters) -Amgen on Thursday said its first-quarter profit rose 24%, driven by product sales, and said that while it is premature to speculate on the impact of U.S. tariffs, tax policy would be a more effective way to …
By Deena Beasley (Reuters) -Amgen on Thursday said its first-quarter profit rose 24%, driven by product sales, and said that while it is premature to speculate on the impact of U.S. tariffs, tax policy would be a more effective way to influence U.S. …
&
